Skip to content
DraconiticResearch
Search Sources API
194,220 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BYMagnetic Resonance in Medical Sciences

MR Imaging of the Upper Urinary Tract: Techniques, Diagnostic Performance, and Imaging Biomarkers

1 more authors

Abstract

MRI has become an increasingly important modality for evaluating the upper urinary tract. Although CT urography remains the standard imaging modality for assessing hematuria, MRI offers distinct advantages, including superior soft-tissue contrast, functional imaging capability, and a radiation-free evaluation, making it particularly valuable in certain clinical scenarios. This review provides a comprehensive overview of MRI of the upper urinary tract, with a focus on upper tract urothelial carcinoma (UTUC). Optimized MRI techniques, including T2-weighted imaging, MR urography, diffusion-weighted imaging (DWI), and contrast-enhanced T1-weighted imaging, are discussed with respect to their complementary roles in tumor detection, characterization, and local staging. MRI findings of UTUC are summarized, emphasizing the role of DWI in improving tumor detection and assessing renal parenchymal invasion. Beyond UTUC, the review addresses MRI features of non-UTUC neoplastic lesions, infectious and inflammatory diseases, and congenital anomalies of the upper urinary tract, underscoring the value of MRI in differential diagnosis. We discuss the potential role of MRI-derived imaging biomarkers, focusing on apparent diffusion coefficient measurements as noninvasive indicators of tumor aggressiveness and invasiveness. We also introduce emerging radiomics approaches as promising, albeit investigational, tools. As technical innovations continue and clinical evidence grows, the role of MRI in the personalized evaluation and management of upper urinary tract diseases is expected to expand.

Related

  1. Diagnostic performance and pathologic associations of the UroVysion assay in patients with upper tract lesions and negative urinary cytology: a large-scale real-world study of 1,256 patients.
    Longtao Zheng, Bao Guan, Zheng Wu +4
    World journal of urologyPeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMC
  2. Magnetic Resonance Imaging in the Preoperative Assessment of Anal Fistula: Diagnostic Performance and Comparison of the St. James and Garg Classifications
    Hung Duy Nguyen, Nhat Anh Thi Tran, Men Thi Nguyen +1
    Journal of ColoproctologyPeer-reviewedCC BYFull textSurgery & anaesthesiaDOAJ
  3. Biomarkers in Acute Mesenteric Ischemia: A Systematic Review of Diagnostic Performance and Injury-Related Signals
    Zelimkhan Berikkhanov, Zakhar Akulov, Ekaterina Klimova +10
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCDOAJ
  4. Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
    Michael Pavlides, Yasaman Vali, Ferenc Emil Mózes +97
    Nature MedicinePeer-reviewedCC BYFull text8 citedEpidemiology & public healthHALOpenAlex
  5. Diagnostic Performance of the Radiographic Assessment of Lung Edema Score for Acute Respiratory Distress Syndrome-Post Hoc Analysis of the "Validating Acute Lung Injury Biomarkers for Diagnosis" Study.
    Claudio Zimatore, Matthieu Jabaudon, Luigi Pisani +3
    Critical care explorationsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{nakamoto2026imaging,
  title = {{MR Imaging of the Upper Urinary Tract: Techniques, Diagnostic Performance, and Imaging Biomarkers}},
  author = {Atsushi Nakamoto and Takashi Ota and Hideyuki Fukui and Toru Honda and Kengo Kiso and Koki Kaketaka and Takumi Tanigaki and Eriko Yoshidome and Feier Ding and Ryo Hirooka and Hiromitsu Onishi and Masatoshi Hori and Noriyuki Tomiyama},
  journal = {Magnetic Resonance in Medical Sciences},
  year = {2026},
  month = jul,
  doi = {10.2463/mrms.rev.2026-0011},
  url = {https://www.jstage.jst.go.jp/article/mrms/25/3/25_rev.2026-0011/_article},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - MR Imaging of the Upper Urinary Tract: Techniques, Diagnostic Performance, and Imaging Biomarkers
AU  - Atsushi Nakamoto
AU  - Takashi Ota
AU  - Hideyuki Fukui
AU  - Toru Honda
AU  - Kengo Kiso
AU  - Koki Kaketaka
AU  - Takumi Tanigaki
AU  - Eriko Yoshidome
AU  - Feier Ding
AU  - Ryo Hirooka
AU  - Hiromitsu Onishi
AU  - Masatoshi Hori
AU  - Noriyuki Tomiyama
PY  - 2026
DA  - 2026/07/14
JO  - Magnetic Resonance in Medical Sciences
DO  - 10.2463/mrms.rev.2026-0011
UR  - https://www.jstage.jst.go.jp/article/mrms/25/3/25_rev.2026-0011/_article
AB  - MRI has become an increasingly important modality for evaluating the upper urinary tract. Although CT urography remains the standard imaging modality for assessing hematuria, MRI offers distinct advantages, including superior soft-tissue contrast, functional imaging capability, and a radiation-free evaluation, making it particularly valuable in certain clinical scenarios. This review provides a comprehensive overview of MRI of the upper urinary tract, with a focus on upper tract urothelial carcinoma (UTUC). Optimized MRI techniques, including T2-weighted imaging, MR urography, diffusion-weighted imaging (DWI), and contrast-enhanced T1-weighted imaging, are discussed with respect to their complementary roles in tumor detection, characterization, and local staging. MRI findings of UTUC are summarized, emphasizing the role of DWI in improving tumor detection and assessing renal parenchymal invasion. Beyond UTUC, the review addresses MRI features of non-UTUC neoplastic lesions, infectious and inflammatory diseases, and congenital anomalies of the upper urinary tract, underscoring the value of MRI in differential diagnosis. We discuss the potential role of MRI-derived imaging biomarkers, focusing on apparent diffusion coefficient measurements as noninvasive indicators of tumor aggressiveness and invasiveness. We also introduce emerging radiomics approaches as promising, albeit investigational, tools. As technical innovations continue and clinical evidence grows, the role of MRI in the personalized evaluation and management of upper urinary tract diseases is expected to expand.
SN  - 1880-2206
SN  - 1347-3182
ER  -